Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Immunogenicity of HPV Vaccine in Transplant Recipients. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunogenicity of the HPV vaccine in kidney transplant recipients. The study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HPV vaccine

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Chronic Kidney Diseases, Kidney Transplant | Phase 4 | Status: ACTIVE_NOT_RECRUITING